Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 12/20 | 0.55 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.54 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.54 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.53 |
| ▸ | SCTR | P47872 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31256793 | 0.97 | OPRM1 (0.55) | GLP1ROPRM1OPRD1OPRK1SCTR | |
| SCHEMBL30407947 | 0.96 | OPRM1 (0.55) | GLP1ROPRM1OPRD1OPRK1 | |
| SCHEMBL30299020 | 0.92 | GLP1R (0.58) | GLP1ROPRM1OPRD1OPRK1 | |
| SCHEMBL31256795 | 0.92 | OPRM1 (0.57) | GLP1ROPRM1OPRD1OPRK1SCTR | |
| SCHEMBL31030934 | 0.91 | GLP1R (0.57) | GLP1ROPRM1OPRD1OPRK1 | |
| SCHEMBL30918524 | 0.91 | GLP1R (0.58) | GLP1ROPRM1OPRD1OPRK1 | |
| SCHEMBL30169866 | 0.90 | GLP1R (0.50) | GLP1ROPRM1OPRD1OPRK1 | |
| SCHEMBL30368416 | 0.90 | OPRM1 (0.56) | GLP1ROPRM1OPRD1OPRK1 | |
| SCHEMBL31258952 | 0.89 | OPRD1 (0.57) | GLP1ROPRM1OPRD1OPRK1SCTR | |
| SCHEMBL31062669 | 0.89 | GLP1R (0.65) | GLP1ROPRM1OPRD1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4434536-A1 | STAPLED PEPTIDE AND USE THEREOF | Medshine Discovery Inc. (CN) | 2024-09-25 | — | — | EP | claimed |
| WO-2025264785-A1 | CHEMICALLY MODIFIED PEPTIDES AND USE THEREOF | NEUROCRINE BIOSCIENCES, INC. (US) | 2025-12-26 | — | — | WO | disclosed |
| WO-2025264809-A1 | CHEMICALLY MODIFIED PEPTIDES AND USE THEREOF | NEUROCRINE BIOSCIENCES, INC. (US) | 2025-12-26 | — | — | WO | disclosed |
| EP-4434536-A1 | STAPLED PEPTIDE AND USE THEREOF | Medshine Discovery Inc. (CN) | 2024-09-25 | — | — | EP | disclosed |
| CN-117024528-B | Preparation method of Retatrutide | 杭州信海医药科技有限公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-117024528-A | Preparation method of Retatrutide | 杭州信海医药科技有限公司 | 2023-11-10 | — | — | CN | disclosed |